CombiMatrix Molecular Diagnostics, Illumina and Burnham Institute, South Korea, and GeneGo | GenomeWeb

In Conference Call, CMD Heads Flesh Out Company's Strategy

The incoming CEO and chief operating officer of CombiMatrix Molecular Diagnostics — a new subsidiary of CombiMatrix that plans to use Combi's technology in a CLIA-approved lab for manufacturing homebrew microarrays — fleshed out the company's strategy in a conference call with investors last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.